Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian P Everall

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
BMJ (Clinical Research Ed.)|November 20, 2019
King's College London clarifies details of inquiry into publications by Eysenck and Grossarth-MaticekIan P Everall
The Australian and New Zealand Journal of Psychiatry|June 24, 2015
RDoC: We should look before we leapSamuel M Lieblich, David J Castle, Ian P Everall
NPJ Schizophrenia|September 1, 2017
Schizophrenia genetics in the genome-wide era: a review of Japanese studiesTetsufumi Kanazawa, Chad A Bousman, Chenxing Liu, et al.
Schizophrenia Research|October 17, 2009
Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorderClare L Beasley, Mrinalini Honavar, Ian P Everall, et al.
AIDS (London, England)|February 9, 2002
Granulocyte-macrophage colony-stimulating factor enhances viral load in human brain tissue: amelioration with stavudineApsara Kandanearatchi, Mark Zuckerman, Melvyn Smith, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 15, 2013
Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendeesChad A Bousman, Maria Potiriadis, Ian P Everall, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 16, 2016
Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort studyChad A Bousman, Jane M Gunn, Maria Potiriadis, et al.
Journal of Affective Disorders|June 3, 2014
G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendeesChad A Bousman, Maria Potiriadis, Ian P Everall, et al.
Schizophrenia Research|May 1, 2018
Decreased peripheral TNF alpha (TNF-α) mRNA expression in patients with treatment-resistant schizophreniaMd Shaki Mostaid, Christos Pantelis, Ian P Everall, et al.
Brain Research|June 24, 2009
Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorderErick T Tatro, Ian P Everall, Marcus Kaul, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|November 20, 2019
King's College London clarifies details of inquiry into publications by Eysenck and Grossarth-MaticekIan P Everall
The Australian and New Zealand Journal of Psychiatry|June 24, 2015
RDoC: We should look before we leapSamuel M Lieblich, David J Castle, Ian P Everall
NPJ Schizophrenia|September 1, 2017
Schizophrenia genetics in the genome-wide era: a review of Japanese studiesTetsufumi Kanazawa, Chad A Bousman, Chenxing Liu, et al.
Schizophrenia Research|October 17, 2009
Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorderClare L Beasley, Mrinalini Honavar, Ian P Everall, et al.
AIDS (London, England)|February 9, 2002
Granulocyte-macrophage colony-stimulating factor enhances viral load in human brain tissue: amelioration with stavudineApsara Kandanearatchi, Mark Zuckerman, Melvyn Smith, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 15, 2013
Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendeesChad A Bousman, Maria Potiriadis, Ian P Everall, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 16, 2016
Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort studyChad A Bousman, Jane M Gunn, Maria Potiriadis, et al.
Journal of Affective Disorders|June 3, 2014
G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendeesChad A Bousman, Maria Potiriadis, Ian P Everall, et al.
Schizophrenia Research|May 1, 2018
Decreased peripheral TNF alpha (TNF-α) mRNA expression in patients with treatment-resistant schizophreniaMd Shaki Mostaid, Christos Pantelis, Ian P Everall, et al.
Brain Research|June 24, 2009
Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorderErick T Tatro, Ian P Everall, Marcus Kaul, et al.
Pageof 8